Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/s0140-6736(20)32381-3 | Breast cancer |
| https://doi.org/10.1016/s1470-2045(19)30718-1 | Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation |
| https://doi.org/10.1016/j.annonc.2023.11.016 | Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up |
| https://doi.org/10.1016/j.radonc.2020.04.003 | Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document |
| https://doi.org/10.1093/annonc/mds619 | Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study |
| https://doi.org/10.1136/esmoopen-2017-000285 | Global cancer control: responding to the growing burden, rising costs and inequalities in access |
| https://doi.org/10.1016/j.radonc.2020.09.008 | Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance |
| https://doi.org/10.1016/s1470-2045(20)30472-1 | Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial |
| https://doi.org/10.1259/bjr.20180270 | Automation in intensity modulated radiotherapy treatment planning—a review of recent innovations |
| https://doi.org/10.1200/jco.22.00644 | Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials |
| https://doi.org/10.1016/j.breast.2020.04.006 | Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic |
| https://doi.org/10.1016/j.annonc.2022.07.007 | ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) |
| https://doi.org/10.1016/j.jtho.2021.03.019 | The HILUS-Trial—a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy |
| https://doi.org/10.1016/j.annonc.2023.08.017 | Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023 |
| https://doi.org/10.1186/s13046-021-02215-y | The CD70-CD27 axis in oncology: the new kids on the block |
| https://doi.org/10.1016/j.breast.2020.02.003 | The requirements of a specialist breast centre |
| https://doi.org/10.1016/s1470-2045(22)00447-8 | European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making |
| https://doi.org/10.1136/esmoopen-2020-000793 | ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer |
| https://doi.org/10.1016/j.jbo.2022.100446 | Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review |
| https://doi.org/10.1016/s1470-2045(22)00752-5 | Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium |
| https://doi.org/10.1016/j.ejca.2023.02.018 | Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| https://doi.org/10.1093/annonc/mdx196 | Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey |
| https://doi.org/10.1016/j.eururo.2019.07.009 | Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy |
| https://doi.org/10.1016/j.radonc.2017.09.001 | The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment |
| https://doi.org/10.1016/j.eururo.2022.04.002 | Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 |
| https://doi.org/10.2807/ese.15.33.19642-en | Laboratory-based surveillance for Cryptosporidium in France, 2006–2009 |
| https://doi.org/10.1016/j.ctrv.2021.102324 | Targeting brain metastases in breast cancer |
| https://doi.org/10.1016/j.eururo.2024.09.017 | Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC) |
| https://doi.org/10.1016/j.ejmp.2021.05.010 | Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives |
| https://doi.org/10.1016/j.breast.2020.05.006 | Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) |
| https://doi.org/10.1002/mp.15222 | FLASH radiotherapy with photon beams |
| https://doi.org/10.1002/mp.15473 | Design, realization, and characterization of a novel diamond detector prototype for FLASH radiotherapy dosimetry |
| https://doi.org/10.1016/j.radonc.2022.10.005 | Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus |
| https://doi.org/10.1002/mp.15668 | Development of an ultra‐thin parallel plate ionization chamber for dosimetry in FLASH radiotherapy |
| https://doi.org/10.1001/jamaoncol.2023.2132 | Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors |
| https://doi.org/10.1016/j.radonc.2020.04.059 | ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer |
| https://doi.org/10.1186/s13045-024-01525-w | IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts |
| https://doi.org/10.1016/j.ejca.2023.03.013 | Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer |
| https://doi.org/10.1038/s41416-022-01859-7 | Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights |
| https://doi.org/10.1186/s12885-020-06911-4 | PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial |
| https://doi.org/10.1016/j.bpobgyn.2022.05.001 | Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities |
| https://doi.org/10.1007/s10549-018-4834-7 | The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome |
| https://doi.org/10.1038/s41585-022-00670-6 | Using PSMA imaging for prognostication in localized and advanced prostate cancer |
| https://doi.org/10.1016/j.jgo.2020.07.013 | Exclusive endocrine therapy or partial breast irradiation for women aged ≥70 years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures |
| https://doi.org/10.1016/j.phro.2020.11.002 | Machine learning applications in radiation oncology: Current use and needs to support clinical implementation |
| https://doi.org/10.1016/s1470-2045(20)30580-5 | Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox |
| https://doi.org/10.1016/j.eururo.2023.10.012 | The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies |
| https://doi.org/10.1016/j.radonc.2020.06.007 | Effect of COVID-19 pandemic on practice in European radiation oncology centers |
| https://doi.org/10.1016/s1470-2045(23)00534-x | International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations |
| https://doi.org/10.1007/s10456-019-09690-0 | Pathological features of vessel co-option versus sprouting angiogenesis |
| https://doi.org/10.1007/s00259-024-06696-9 | Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer |
| https://doi.org/10.1016/j.radonc.2018.07.025 | Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR |
| https://doi.org/10.1016/j.radonc.2023.109947 | Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform |
| https://doi.org/10.1016/s1470-2045(24)00730-7 | ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial |
| https://doi.org/10.1186/s12885-019-5676-3 | PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer |
| https://doi.org/10.1093/annonc/mdy210 | Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium |
| https://doi.org/10.1001/jamaoncol.2020.7468 | Association of Breast Cancer Irradiation With Cardiac Toxic Effects |
| https://doi.org/10.1016/j.lungcan.2020.08.017 | European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer |
| https://doi.org/10.1016/j.ijom.2019.04.018 | Does intensity-modulated radiation therapy lower the risk of osteoradionecrosis of the jaw? A long-term comparative analysis |
| https://doi.org/10.1016/j.radonc.2020.01.005 | Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome |
| https://doi.org/10.1016/j.ijrobp.2023.10.031 | Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses |
| https://doi.org/10.1016/s1470-2045(24)00661-2 | Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial |
| https://doi.org/10.1016/j.critrevonc.2020.103090 | The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review |
| https://doi.org/10.1016/j.critrevonc.2021.103391 | The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review |
| https://doi.org/10.1093/bjs/znac217 | Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey |
| https://doi.org/10.1002/mp.15782 | Application of a novel diamond detector for commissioning of FLASH radiotherapy electron beams |
| https://doi.org/10.1016/j.ijrobp.2023.03.064 | Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial) |
| https://doi.org/10.1016/j.breast.2022.03.008 | Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy |
| https://doi.org/10.1016/s1470-2045(25)00197-4 | Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V–STORM): a phase 2, open-label, randomised controlled trial |
| https://doi.org/10.1016/j.ejmp.2022.08.010 | A new solution for UHDP and UHDR (Flash) measurements: Theory and conceptual design of ALLS chamber |
| https://doi.org/10.1016/j.radonc.2023.109805 | Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis |
| https://doi.org/10.1016/j.annonc.2023.08.001 | ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC) |
| https://doi.org/10.1038/s41391-020-00304-1 | Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer |
| https://doi.org/10.1093/jnci/djab113 | Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925 |
| https://doi.org/10.1186/s12885-020-07055-1 | Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial |
| https://doi.org/10.1016/j.ijrobp.2020.11.045 | The Dutch–Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases |
| https://doi.org/10.1016/j.ijrobp.2024.02.015 | Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy |
| https://doi.org/10.1016/s0140-6736(20)31240-x | Cancer and COVID-19: what do we really know? |
| https://doi.org/10.1016/j.ijrobp.2021.08.036 | Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study |
| https://doi.org/10.1200/jco.22.01485 | Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial |
| https://doi.org/10.3390/app13052986 | First Characterization of Novel Silicon Carbide Detectors with Ultra-High Dose Rate Electron Beams for FLASH Radiotherapy |
| https://doi.org/10.1016/j.ejmp.2022.10.005 | Point scintillator dosimetry in ultra-high dose rate electron “FLASH” radiation therapy: A first characterization |
| https://doi.org/10.1001/jamanetworkopen.2023.55409 | Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases |
| https://doi.org/10.1016/j.breast.2022.01.018 | Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials |
| https://doi.org/10.1016/j.ijrobp.2023.06.246 | Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors |
| https://doi.org/10.1093/neuonc/noae053 | Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial |
| https://doi.org/10.1016/s1470-2045(23)00286-3 | Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups |
| https://doi.org/10.1016/j.eururo.2023.05.005 | Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty |
| https://doi.org/10.1016/s1470-2045(24)00023-8 | Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology |
| https://doi.org/10.1016/j.breast.2024.103674 | Breast cancer highlights from 2023: Knowledge to guide practice and future research |
| https://doi.org/10.1002/cncr.35310 | Dose‐intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial |
| https://doi.org/10.1016/j.ejca.2024.115064 | Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group |
| https://doi.org/10.1016/j.annonc.2023.04.515 | Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer |
| https://doi.org/10.1016/j.radonc.2023.110060 | Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) |
| https://doi.org/10.1016/j.eururo.2023.04.025 | Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer |
| https://doi.org/10.1136/bmj-2023-079089 | Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis |
| https://doi.org/10.1007/s00455-022-10513-6 | Increasing Adherence to Prophylactic Swallowing Exercises During Head and Neck Radiotherapy: The Multicenter, Randomized Controlled PRESTO-Trial |
| https://doi.org/10.1016/j.radonc.2024.110507 | Recording and reporting of ultra-high dose rate “FLASH” delivery for preclinical and clinical settings |
| https://doi.org/10.1136/jitc-2023-007279 | First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial |
| https://doi.org/10.1016/j.radonc.2024.110235 | Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study |